特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
955731

使い捨てシリンジの世界市場:2020-2027年

Global Disposable Syringes Market - 2020-2027

出版日: | 発行: DataM Intelligence | ページ情報: 英文 | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
使い捨てシリンジの世界市場:2020-2027年
出版日: 2020年08月31日
発行: DataM Intelligence
ページ情報: 英文
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

使い捨てシリンジ市場は、使い捨てシリンジの使用に対する関心を高める様々なNGOによる活動の増加、HIVのような病気のまん延を制御する必要性、および注射剤に対する需要の高まりによって促進されています。注射剤は、体循環に直接入り、作用がより速く開始されることで望ましい効果を提供します。さらに、針刺しによるけがのケースが増えてことも、安全なシリンジに対する需要を高めています。これらの利点は、注射剤の採用の増加と、その結果としての世界の使い捨てシリンジ市場の成長にも貢献しています。加えて、ワクチンの需要の高まりにより、世界の新興地域におけるシリンジ、特に使い捨てシリンジの販売が促進されることが期待されています。また、COVID-19の大流行で感染した患者への投薬により、使い捨てシリンジの需要が高まっています。しかし、安全な使い捨てシリンジの高コスト性は市場の成長を抑制しています。

当レポートでは、世界の使い捨てシリンジ市場について調査し、市場の概要、各セグメントおよび地域別による市場規模の予測、主要企業のプロファイル、競合情勢の分析など、体系的な情報を提供しています。

目次

第1章 世界の使い捨てシリンジ市場:調査範囲・調査手法

  • 調査手法
  • 調査目的・範囲

第2章 世界の使い捨てシリンジ市場:市場の定義と概要

第3章 世界の使い捨てシリンジ市場:エグゼクティブサマリー

  • 市場内訳:製品別
  • 市場内訳:アプリケーション別
  • 市場内訳:エンドユーザー別
  • 市場内訳:地域別

第4章 世界の使い捨てシリンジ市場:市場ダイナミクス

  • 市場影響要因
    • 促進要因
    • 抑制要因
  • 厳しい政府規制
  • 市場機会

第5章 世界の使い捨てシリンジ市場:業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 規制分析
  • 価格分析
  • 製品分析
  • ポストセールスサービス分析

第6章 世界の使い捨てシリンジ市場:製品別

  • イントロダクション
  • 市場規模分析・前年比成長率分析:製品別
  • 市場魅力度指数:製品別
    • 従来の使い捨てシリンジ
    • 安全な使い捨てシリンジ
    • 経口シリンジ
    • 充填針

第7章 世界の使い捨てシリンジ市場:アプリケーション別

  • イントロダクション
  • 市場規模分析・前年比成長率分析:アプリケーション別
  • 市場魅力度指数:アプリケーション別
    • 治療注射

第8章 世界の使い捨てシリンジ市場:エンドユーザー別

  • イントロダクション
  • 市場規模分析・前年比成長率分析:エンドユーザー別
  • 市場魅力度指数:エンドユーザー別
    • 診断ラボ
    • 血液バンク
    • 医薬品業界
    • 予防接種
    • 動物用

第9章 世界の使い捨てシリンジ市場:地域別

  • イントロダクション
    • 市場規模分析・前年比成長率分析:地域別
    • 市場魅力度指数:地域別
  • 北米
    • イントロダクション
    • 主な地域固有のダイナミクス
    • 市場規模分析・前年比成長率分析:タイプ別
    • 市場規模分析・前年比成長率分析:製品別
    • 市場規模分析・前年比成長率分析:アプリケーション別
    • 市場規模分析・前年比成長率分析:エンドユーザー別
    • 市場規模分析・前年比成長率分析:国別
  • 欧州
  • 南米
  • アジア太平洋
  • 中東・アフリカ

第10章 世界の使い捨てシリンジ市場:競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第11章 企業プロファイル

  • Baxter International Inc.
    • 企業概要
    • ポートフォリオ・説明
    • 主なハイライト
    • 財務概要
  • B. Braun Melsungen AG
  • Becton
  • Dickinson and Company
  • Cardinal Health
  • Henke-Sass Wolf
  • Nipro Medical Corporation
  • Novo Nordisk A/S
  • Retractable Technologies, Inc.
  • Vita Needle Company

第12章 世界の使い捨てシリンジ市場:重要考察

第13章 世界の使い捨てシリンジ市場:DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次

Market Overview

A syringe which is designed for one time use and is discarded after the use is called as a disposable syringe. Furthermore, a syringe is defined as a sterile cylindrical medical instrument which has a thin hollow needle at the end. In addition, this device acts as a pump, which is used to draw therapeutic liquid formulation from vials and deliver them to the blood stream of a patient. However within more modern times the disposable syringe has risen in popularity over the traditional reusable syringe. The primary difference being that a disposable syringe is intended for one-time use and is then disposed of, typically into a contamination unit.

Different syringes will take on different sizes dependent on whether they are being used for injection, tubing, or irrigation. This is due to the relationship of volume and pressure. Smaller syringes (1 - 10ml) are typically used to inject medication into a patient while large syringes (20 - 70ml) with higher volume are typically used for irrigation. Most medium sized syringes which occupy the territory of 10 to 12ml are used for tubing, such as with catheters and other medical tubing's.

Market Dynamics:

The market is driven by the increasing number of activities by various NGO's that create awareness for the use of disposable syringes, need to control the spread of diseases like HIV, and rising demand of injectable drugs.

There has been a marked increase in the use of injectable drugs, primarily due to the lack of bioavailability in conventional drug delivery methods. A large number of orally administered drugs are subject to decomposition during the first-pass metabolism, which renders them ineffective by the time they reach the systemic circulation. On the other hand, injectable drugs directly enter the systemic circulation and provide the desired effect with the quicker onset of action. Furthermore, there are rising cases of needle stick injuries are driving the demand for the safety syringes. These advantages are also responsible for increased adoption of injectable drug and the consequent growth of the global disposable syringes market. Furthermore, the increasing demand for vaccines is expected to drive the sales of syringes particularly disposable syringes in the developing regions of the world.

Sustained growth of the injectable drugs sector, which primarily includes biologics, is the major factor driving the global disposable syringes market. More than 60% drugs in clinical development are biologics. This indicates strong growth of the biologics market. In turn, this is expected to boost the disposable syringes market. Rise in demand for point-of-care administration and technological advancements in the manufacturing of disposable syringes are fueling the global disposable syringes market.

Groundbreaking innovations such as the introduction of two-step disposable autoinjector devices are bolstering the growth of the global disposable syringes market. Companies in the market for disposable syringes are increasing efforts to introduce devices that cater to different viscosities in drugs. They are increasing focus to deliver design improvements in devices that are eliminating the need for customizing system components. Novel two-step disposable autoinjector devices are overcoming challenges of breakage and incompatibility associated with poorly integrated systems.

However, high cost of safety disposable syringes restricts market growth. Conversely, high growth potential in developing economies is expected to offer lucrative opportunities during the forecast period.

With the COVID-19 pandemic outbreak, the demand of disposable syringes is increasing due to the medication of infected patients. The companies has increased their production so that there is no shortage of disposable syringes to the hospitals. This factor will drive the growth of the market in the forecast period.

Segment Analysis

The global disposable syringes market is segmented based on product by conventional disposable syringes, safety disposable syringes, needles, oral syringes, and filling needles. The safety disposable syringes segment held the largest market share due to reducing needle stick injuries. The most notable difference between a safety syringe and its standard counterpart is the presence of a plastic shield which surrounds the needle and locks into place once the needle has been used. Most safety syringes also include plastic sheaths that can be opened and closed. This allows for safe transport and storage of the syringe during patient care. Further, these types of sheaths allow for safe disposal of the needle and removal of used needles from the health care facility.

While the introduction of universal precautions and safety-conscious needle designs has led to a decline in such type of injuries. Awareness of needle stick injuries started to develop soon after the identification of HIV and today the major concern after a needle stick injury is not HIV but hepatitis B or hepatitis C. The safety syringes can be segmented into retractable safety syringes and non-retractable safety syringes. A safety syringe is equipped with a sheath that automatically extends over the needle of the syringe after the syringe has been used to administer the injection. Safety syringes can help in the prevention of transmission of diseases, like AIDS and Hepatitis, among healthcare workers. Additionally, safety syringes help to avert all types of needle stick injuries.

According to the WHO, 3 million accidental needle-stick injuries were reported in 2003, with 37% new hepatitis B cases in health care workers, 39% of new hepatitis C cases, and around 5.5% of new HIV cases. Moreover, around 422 million people had diabetes across the world in 2016. Increase in health care spending, rise in prevalence of blood borne diseases, and surge in awareness about the benefits of safety syringes drive the global safety syringes market.

The oral syringes segment is expected to have positive market growth in the forecast period. Oral syringes are used to deliver medication orally directly in the mouth of the patient. They are designed in such a way that it reduces the risk of medication dosing thus curbing chances of administrative error. Oral syringes can meet patient needs of all the age groups, and this syringes can be used several times by an individual patient within a time frame of seven days. Parent market for oral syringes is the medical syringes with a needle and some possible related markets for oral syringes are injection pens, specialty needles, and insulin pumps. Over the years, the market has evolved from using dosing cups, droppers and the use of teaspoon while consuming liquid medication to the use of oral syringes to increase chances of giving correct doses.

As there is a growing prevalence of acute diseases caused due to improper amount of consumption of doses thus the need for accurate consumption of medication has increased leading to the growth of oral syringes segment across the world. Oral syringes are easy to use and can also be pre-sterilized so that it can be re-used and also helps in reducing the drug losses. These all factors together drive the oral syringe segment.

Further, the market is also classified based on application as immunization injections, and therapeutic injections. Therapeutic injections are joint injections administered for the relief of chronic pain and inflammation. They are used in patients who are experiencing either acute or chronic discomfort but are usually reserved for patients who have not achieved desirable relief from more conservative measures like physical therapy. There are several types of therapeutic joint injections, the most common of which are steroidal injections. Many injections are designed to provide immediate relief following the injections, as well as slow-release treatment over the course of several weeks or months after the injection.

The therapeutic injections segment is expected to have positive market growth due to the growing demand for injectable to treat diseases. According to the WHO, around 90% of products are used for therapeutic care. Treatment of diabetes by delivering insulin comprises a large share in therapeutic injections. High prevalence of diseases such as HIV infection, malaria, tuberculosis, and dengue results in high consumption of injections, which are used in the diagnosis and treatments of these diseases.

Introduction of new injectable drugs is also expected to augment the industry growth. In August 2015, CytoDyn, Inc. announced the initiation of a clinical trial of their injectable HIV drug. This injectable was expected to replace the daily antiretroviral pill dose with a once-a-week injection, thus improving the quality of life of the 33 million people living with AIDS

The immunization injections is expected to have positive market growth in the forecast period. Immunizations injections protects from serious diseases and also prevent the spread of those diseases to others. Over the years immunizations injections have thwarted epidemics of once common infectious diseases such as measles, mumps, and whooping cough.

According to the UNICEF in May 2020, 99 countries reported the termination of the immunization campaigns for measles, polio, meningococcal, DTP, and many other antigens. This factor will drive the growth of the segment in the forecast period.

Geographical Presentation

By region, the global disposable syringes market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the global disposable syringes market and is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of the market include rising cases of diabetes and the presence of better healthcare infrastructure. As per American Diabetes Association (ADA), in 2017, around 34.2 million Americans, who account for nearly 10.5% of the population, had diabetes and approximately 1.6 million American children and adults had type 1 diabetes. Taking insulin is an important management technique for millions who have diabetes and the most common method for insulin delivery in the United States is injection with the help of a syringe.

Furthermore, there is a rising prevalence of chronic diseases in the United States which is helping the market to grow in the region. Thus, owing to the all the mention factors the market is expected to witness high growth over the forecast period.

The Asia-Pacific region is expected to have third-largest share due improving economic conditions, rise in purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient pool suffering from various chronic diseases are expected to drive the market. In Asia-Pacific, Japan accounts for the major share of the market by revenue as well as volume, owing to the increased demand for self-administered treatments and high penetration of self-injection devices, growing the aging population, and increasing the prevalence of diabetes.

Competitive Analysis

The global disposable syringes market is highly competitive with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition Baxter International Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Cardinal Health, Henke-Sass Wolf, Nipro Medical Corporation, Novo Nordisk A/S, Retractable Technologies, Inc., are the leading market players with significant market share. The major players are using product development, novel product launches, market expansion, and product diversification strategies for holding their position in the market.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to expand their presence and meet the rising demand for the dental implants across the globe. For instance, in October 2016, B Braun scheduled launch of its echogenic peripheral nerve block needle technology, the Stimuplex Ultra 360. The launch was to be presented in the American Society of Anesthesiologists Annual Meeting.

  • In April 2019, Fresenius Kabi launched Adenosine Injection, USP in 6 mg per 2 mL and 12 mg per 4 mL single dose in simplest ready-to-administer prefilled syringes in the United States. Fresenius Kabi has sold 6 mg per 2 mL and 12 mg per 4 mL Adenosine Injection, USP vial presentations since 2013 and 60 mg per 20 mL and 90 mg per 30 mL vial presentations since 2018.
  • In October 2019, BD launch of the BD Intevia™ 1 mL two-step disposable autoinjector, a robust platform device combining autoinjector and pre-fillable syringe in one integrated system. The announcement was made at the Parental Drug Association's 2019 Universe of Pre-Filled Syringes and Injection Devices conference being held in Gothenburg, Sweden.

Why Purchase the Report?

  • Visualize the composition of the global disposable syringes market products in terms of product, application and end-user and highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the global disposable syringes market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global disposable syringes market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

*The global disposable syringes market report will provide access to approximately 60 market data tables, 47 figures, and 200 pages.

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Table of Contents

1. Global Disposable Syringes Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Disposable Syringes Market - Market Definition and Overview

3. Global Disposable Syringes Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End-User
  • 3.4. Market Snippet by Region

4. Global Disposable Syringes Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Activities by Various NGO's that Create Awareness for the Use of Disposable Syringes
      • 4.1.1.2. Need to Control the Spread of Diseases like HIV
      • 4.1.1.3. Rising Demand of Injectable Drugs
    • 4.1.2. Restraints
      • 4.1.2.1. Comparatively High One-time Cost
  • 4.2. Stringent Government Regulations
  • 4.3. Opportunity

5. Global Disposable Syringes Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Product Analysis
  • 5.6. Post Sales Services Analysis

6. Global Disposable Syringes Market - By Product

  • 6.1. Introduction
  • 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
  • 6.3. Market Attractiveness Index, By Product
    • 6.3.1. Conventional Disposable Syringes *
      • 6.3.1.1. Introduction
      • 6.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 6.3.2. Safety Disposable Syringes
    • 6.3.3. Needles
    • 6.3.4. Oral Syringes
    • 6.3.5. Filling Needles

7. Global Disposable Syringes Market - By Application

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  • 7.3. Market Attractiveness Index, By Application
      • 7.3.1.1. Immunization injections
      • 7.3.1.2. Introduction
      • 7.3.1.3. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 7.3.2. Therapeutic injections

8. Global Disposable Syringes Market - By End-User

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  • 8.3. Market Attractiveness Index, By End-User
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Introduction
      • 8.3.1.3. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Blood Banks
    • 8.3.4. Pharmaceutical Industry
    • 8.3.5. Vaccination
    • 8.3.6. Veterinary Purposes

9. Global Disposable Syringes Market - By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. U.S.
      • 9.4.7.2. Canada
      • 9.4.7.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. Germany
      • 9.5.6.2. U.K.
      • 9.5.6.3. France
      • 9.5.6.4. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.6.1. Brazil
      • 9.6.6.2. Argentina
      • 9.6.6.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.6.1. China
      • 9.7.6.2. India
      • 9.7.6.3. Japan
      • 9.7.6.4. Australia
      • 9.7.6.5. Rest of Asia Pacific
  • 9.8. Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Production
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Global Disposable Syringes Market Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Global Disposable Syringes Market Company Profiles

  • 11.1. Baxter International Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Developments
    • 11.1.4. Financial Overview
  • 11.2. B. Braun Melsungen AG
  • 11.3. Becton
  • 11.4. Dickinson and Company
  • 11.5. Cardinal Health
  • 11.6. Henke-Sass Wolf
  • 11.7. Nipro Medical Corporation
  • 11.8. Novo Nordisk A/S
  • 11.9. Retractable Technologies, Inc.
  • 11.10. Vita Needle Company
  • List is not exhaustive

12. Global Disposable Syringes Market - Premium Insights

13. Global Disposable Syringes Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.